Tumour-reactive T cell subsets in the microenvironment of ovarian cancer-Reference-Cited by-同舟云学术

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

Published:2019-02 Issue:4 Volume:120 Page:424-434
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Westergaard Marie Christine Wulff,Andersen Rikke,Chong Chloé,Kjeldsen Julie Westerlin,Pedersen Magnus,Friese Christina,Hasselager Thomas,Lajer Henrik,Coukos George,Bassani-Sternberg Michal,Donia Marco,Svane Inge Marie

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-019-0384-y.pdf

Reference43 articles.

1. Gooden, M. J. M., de Bock, G. H., Leffers, N., Daemen, T. & Nijman, H. W. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br. J. Cancer 105, 93–103 (2011).

2. Adams, S. F. et al. Intraepithelial T cells and tumour proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer. Cancer 115, 2891–2902 (2009).

3. Zhang, L. et al. Intratumoural T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348, 203–213 (2003).

4. Sato, E. et al. Intraepithelial CD8+tumour-infiltrating lymphocytes and a hiThe Danish National Committee on Health Research Ethics approved the scientific use of the patient material (protocol number H-2–2014–055).gh CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. USA 102, 18538–18543 (2005).

5. Kvistborg, P., van Buuren, M. M. & Schumacher, T. N. Human cancer regression antigens. Curr. Opin. Immunol. 25, 284–290 (2013).

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for response to TIL therapy: a comprehensive review;Journal for ImmunoTherapy of Cancer;2024-03

2. Tumor immunity: A brief overview of tumor‑infiltrating immune cells and research advances into tumor‑infiltrating lymphocytes in gynecological malignancies (Review);Experimental and Therapeutic Medicine;2024-02-26

3. Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer;Biology;2023-12-05

4. Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine;Cancer Gene Therapy;2023-09-04

5. Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer;Journal of Ovarian Research;2023-06-15